These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29147811)

  • 1. C-terminal region of human p53 attenuates buffalo p53 N-terminal-specific transactivation of p21 promoter by modulating tetramerization of the protein.
    Singh M; Mukhopadhyay T
    Mol Cell Biochem; 2018 Jun; 443(1-2):101-110. PubMed ID: 29147811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation, characterization and functional analysis of full length p53 cDNA from Bubalus bubalis.
    Singh M; Aggarwal S; Mohanty AK; Mukhopadhyay T
    Gene; 2015 Sep; 568(2):146-54. PubMed ID: 26003295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1-mediated DNA bending: Distinct roles in increasing p53 binding to DNA and the transactivation of p53-responsive gene promoters.
    Štros M; Kučírek M; Sani SA; Polanská E
    Biochim Biophys Acta Gene Regul Mech; 2018 Mar; 1861(3):200-210. PubMed ID: 29421308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway.
    Zhang G; Chen F; Cao Y; See WA
    Urol Oncol; 2007; 25(3):221-7. PubMed ID: 17483019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hetero-oligomerization does not compromise 'gain of function' of tumor-derived p53 mutants.
    Deb D; Scian M; Roth KE; Li W; Keiger J; Chakraborti AS; Deb SP; Deb S
    Oncogene; 2002 Jan; 21(2):176-89. PubMed ID: 11803461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysines in the tetramerization domain of p53 selectively modulate G1 arrest.
    Beckerman R; Yoh K; Mattia-Sansobrino M; Zupnick A; Laptenko O; Karni-Schmidt O; Ahn J; Byeon IJ; Keezer S; Prives C
    Cell Cycle; 2016 Jun; 15(11):1425-38. PubMed ID: 27210019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of p21 is upregulated by forkhead box A1/2 in p53-null H1299 cells.
    An JH; Jang SM; Kim JW; Kim CH; Song PI; Choi KH
    FEBS Lett; 2014 Nov; 588(21):4065-70. PubMed ID: 25281925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV; Das GC
    Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
    Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
    J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual regulatory roles of human AP-endonuclease (APE1/Ref-1) in CDKN1A/p21 expression.
    Sengupta S; Mitra S; Bhakat KK
    PLoS One; 2013; 8(7):e68467. PubMed ID: 23874636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of R213 mutation on p53-mediated p21 activity.
    Zhang Y; Zhang YJ; Zhao HY; Zhai QL; Zhang Y; Shen YF
    Biochimie; 2014 Apr; 99():215-8. PubMed ID: 24384472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
    Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
    Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding.
    Gong GZ; Jiang YF; He Y; Lai LY; Zhu YH; Su XS
    World J Gastroenterol; 2004 Aug; 10(15):2223-7. PubMed ID: 15259070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.
    Zacharatos PV; Gorgoulis VG; Kotsinas A; Manolis EN; Liloglou T; Rassidakis AN; Kanavaros P; Field JD; Halazonetis T; Kittas C
    Anticancer Res; 1999; 19(1A):579-87. PubMed ID: 10226602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain.
    Roth J; Koch P; Contente A; Dobbelstein M
    Oncogene; 2000 Mar; 19(14):1834-42. PubMed ID: 10777217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac transcription factor Nkx2.5 interacts with p53 and modulates its activity.
    Kojic S; Nestorovic A; Rakicevic L; Protic O; Jasnic-Savovic J; Faulkner G; Radojkovic D
    Arch Biochem Biophys; 2015 Mar; 569():45-53. PubMed ID: 25677450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
    Liu WL; Midgley C; Stephen C; Saville M; Lane DP
    J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression.
    Choi BH; Kim CG; Bae YS; Lim Y; Lee YH; Shin SY
    Cancer Res; 2008 Mar; 68(5):1369-77. PubMed ID: 18316600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.